The Living Enterprise
The Longevity Problem
In 1958, the average firm on the S&P 500 could expect to live 61 years. Today that number is closer to 18. Research from Innosight projects a fall into the low double digits by 2030. A CEO joining a Fortune 500 firm today has a better-than-even chance of seeing it exit the index before she retires.
Most of these companies will not die from an external shock. They will die from internal pathologies that the management literature keeps describing qualitatively and diagnosing late.
Kodak invented the digital camera and held more than a thousand digital imaging patents. It could not translate them into product. Nokia had the market share, the technology, and the engineering talent; middle managers who saw the iPhone threat were silenced by top-management fear. Boeing’s governance chart looked exemplary while its tacit rules drifted toward schedule compression over safety. Wirecard’s auditors signed off for a decade while short-sellers documented fraud in public. Each post-mortem reads as a specific tragedy. Across dozens of cases, a pattern emerges.
Enterprises fail in six predictable ways. The same six ways, across industries and decades, in cascading sequences we can map and therefore anticipate.
The same six layers already exist — fully differentiated, exquisitely regulated, and tested by 3.8 billion years of selection — inside every cell in your body.
This article proposes a framework I call the Living Enterprise 6 (LE6). It treats the enterprise as a living system whose six architectural components — governance, leadership, management, workers, security, and external environment — correspond to six components of the biological cell. The mapping is not metaphor. It is a transfer of first principles from a system that has solved the organizational-survival problem to one that keeps failing it. And it yields something the existing canon of strategy frameworks does not: a specific, measurable vocabulary for whether your company will thrive, sustain, grow — or quietly die.
The Six Layers
A cell is coordinated by six functions. So is an enterprise. Each is independently necessary. Each failure mode is specific. Each has a diagnostic vocabulary we can borrow from biology.
These layers are not a checklist. They form a feedback loop. Governance specifies what should be built. Leadership mobilizes energy and points it toward opportunity. Management translates direction into executable instructions. Workers execute. Security keeps out what harms and admits what helps. The environment supplies resources and signals back whether the organism still belongs. That signal travels up to governance, which adjusts what is expressed next. When the loop is intact, the organism adapts. When one link fails, the cascade begins.
The rest of this article walks each layer. The biological first principle. The executive diagnostic. At least one cautionary case.
Governance: The Code
DNA is the cell’s constitution. It is a four-letter sequence that encodes every protein the cell can make, every regulatory element that decides when, and every safeguard that punishes violation. Three features matter for executives.
Selective expression. Of roughly 20,000 human genes, only a fraction is expressed in any given cell at any given moment. The cell chooses. Liver cells express a different set than neurons, though both carry identical DNA. The mechanism is transcriptional regulation, orchestrated by some 1,600 transcription factors and a layer of epigenetic marks that functions as the cell’s policy interpretation. The written genome rarely changes. The expressed genome changes constantly.
Error correction. DNA replication achieves an error rate near one in a billion base pairs. Three proofreading layers stack: base selection, polymerase proofreading, and post-replicative mismatch repair. When damage occurs anyway, the tumor suppressor p53 — called “the guardian of the genome” — arrests the cycle, repairs if possible, and forces the cell to commit suicide if not.
Regulated variation. DNA is not frozen. Mutation and recombination permit evolution. But variation is disciplined. Most mutations are corrected. The rest are selected against, or, rarely, preserved as adaptation.
The Enterprise Translation
Governance is not the policy binder. It is the enterprise’s operating code: the rules, oversight structures, and proofreading mechanisms that determine what the organization can do, must do, and must not do. It includes the board’s committees, the audit function, the risk charter, the code of conduct, the whistleblower channel — and, most consequentially, the tacit epigenetic layer of cultural norms that decides which written rules actually bind in practice.
The agency tradition from Jensen and Meckling maps cleanly: governance constrains agent discretion. Stewardship theory (Davis, Schoorman, Donaldson) supplies the necessary counterweight — governance is also enabling, letting the organization act coherently toward shared ends. Ostrom’s eight design principles for governing common-pool resources, which earned her the Nobel, describe precisely the recursive, nested control architecture that DNA implements.
The Diagnostic
Can every material decision point to at least two independent proofreading layers — management review plus board oversight plus external audit? When a violation is detected, what is the measured latency from detection to containment to remediation? Does a functional p53 — an oversight body with real authority to halt growth that violates the rules — exist, and is it actually used? Is written policy congruent with lived practice, or has epigenetic drift rewritten the rules through tacit behavior? Can the organization kill its own products, divisions, or projects when they violate governance, or do zombie units persist?
The Cautionary Case
Boeing is the instructive example precisely because its formal governance looked exemplary. A well-staffed board. Independent audit. FAA oversight. Every box ticked. But the 737 MAX disasters revealed that Boeing’s epigenetic layer — the unwritten understanding of what was allowed — had shifted toward schedule compression and cost control over a decade of incentive drift. Engineers who flagged concerns about MCAS were overruled. The written DNA was unchanged. The expressed DNA had been quietly rewritten.
The pattern generalizes. Wirecard was tumor-suppressor loss: the auditors had been captured. FTX was DNA absence: Bankman-Fried ran a firm with effectively no board. Enron was epigenetic reprogramming combined with disabled proofreading. Wells Fargo’s account-opening scandal was a cultural-expression shift on top of formally intact policy. In every case, an executive reading the org chart would have seen no problem. The diagnostic that matters is the expressed governance, not the written one.
Leadership: Energy and Direction
Leadership in a cell is a dual function. The cell needs energy to do anything. It also needs direction to know where to go. Neither substitutes for the other.
Energy. The mitochondrion generates ATP, the universal currency of cellular work. A resting human resynthesizes roughly 60 kilograms of ATP each day. Capacity scales with demand via PGC-1α, the master regulator of mitochondrial biogenesis, up-regulated by exercise, stress, and caloric restriction. When mitochondria fail, everything downstream fails with them. Mitochondrial dysfunction is causally implicated in aging, Parkinson’s disease, sarcopenia, type 2 diabetes, and heart failure.
Direction. Cells navigate chemical gradients toward nutrients and away from toxins. Bacteria too small to detect a spatial gradient use a run-and-tumble algorithm, comparing concentrations over a 1–4 second memory window. The foundational theoretical result is Berg and Purcell’s 1977 paper on the physics of chemoreception. It proves a physical lower bound on sensing precision: no sensor, biological or engineered, can detect a gradient more precisely than a formula involving diffusion, sensor size, and averaging time. Precision improves only as the square root of averaging time. Below that floor, signal is indistinguishable from noise.
Four consequences follow for any system trying to sense direction. First, there is an irreducible noise floor. Second, averaging takes time, and impatience produces false signals. Third, sensor coverage matters — but only a small fraction of surface area need be sensors for near-optimal capture. Fourth, adaptation is essential: the baseline must continuously reset, or novel signals disappear into background.
The Enterprise Translation
Leadership is the mitochondrial and chemotactic function of the firm. It generates energy — what practitioners call spirit, will, inspiration — and it senses direction — what practitioners call vision, strategy, market sensing. The transformational leadership tradition from Burns and Bass isolates the two streams; servant leadership (Greenleaf) specifies that the energy is directed downward toward those doing the catalytic work; Level 5 leadership (Collins) defines the combination of humility and professional will that sustains output without destroying the cell. Karl Weick’s sensemaking research is, effectively, gradient sensing under Berg–Purcell constraints — constructing meaning from ambiguous cues under a hard noise floor.
The Diagnostic
Is leadership energy visible and sustained, or is the organization running on fumes? When demands rise, does leadership capacity expand — new senior hires, internal bench development, visible biogenesis — or does the existing team burn out? How many independent environmental sensors does the firm maintain, and is the averaging window calibrated to the decision? Does leadership continuously reset its baseline, so that novel signals actually register — or has it anchored on the conditions of its own founding? Does the firm maintain deliberate tumbles — strategy resets, hypothesis tests, pivot criteria — or does it run indefinitely in the direction that last worked?
The Cautionary Case
Dick Fuld at Lehman Brothers displayed the classic adaptation failure. The aggressive leverage playbook that had worked through multiple cycles was executed into 2008 without recognizing that the gradient had reversed. Travis Kalanick at Uber showed the opposite pathology: mitochondrial hyperactivity with no quality control, producing the cultural equivalent of oxidative damage. Elizabeth Holmes at Theranos combined charismatic energy output with a profound chemotaxis failure — an inability to read negative signals about the underlying technology. In each case the individual’s talent was not the issue. The leadership function was doing one of its two jobs and not the other.
Management: The Translation Layer
If governance is the code and leadership is energy-and-direction, management is where strategy becomes product. The cellular machinery is specific.
Ribosomes read messenger RNA and catalyze peptide-bond formation at roughly five amino acids per second, with an error rate near one in ten thousand. The endoplasmic reticulum hosts the co-translational folding of secretory and membrane proteins, supervised by chaperones whose entire job is to ensure newly made polypeptides reach their functional shape. The Golgi apparatus performs post-translational modification, sorting, and routing; SNARE addressing ensures that vesicles fuse only with their correct target membranes.
Two mechanisms deserve the executive’s attention.
The unfolded protein response (UPR). A three-sensor system detects accumulating misfolded protein, halts new translation, up-regulates chaperone capacity, and — if stress persists — triggers apoptosis. It is a graded, three-stage response: slow intake, upgrade capacity, controlled termination. Chronic failure of the UPR produces the proteinopathies: Alzheimer’s, Parkinson’s, cystic fibrosis, diabetes. At the cellular level, these are diseases of the management layer.
Michaelis–Menten saturation. Each enzyme has a substrate concentration at which it works at half-maximum velocity and a maximum velocity it cannot exceed. Pile on more substrate past that point, and throughput plateaus while the probability of misfolding rises. Goldratt rediscovered this for factories in the 1980s as the Theory of Constraints. Cells have always known it.
The Enterprise Translation
Management is the ribosomal function: it reads the strategic mRNA and produces the proteins of daily output. Drucker’s Management by Objectives is, literally, the ribosomal algorithm. The Toyota Production System is the industrial engineering of flow, just-in-time synthesis, and jidoka — stop-the-line quality control. The DORA metrics in software — deployment frequency, lead time, change-failure rate, mean time to recover — are ribosomal throughput and fidelity measures. Gallup’s meta-analyses find that managers account for roughly 70% of the variance in team engagement. The translation layer dominates output variance.
The Diagnostic
Can every manager at every level articulate the top three strategic objectives and name the key results their team owns? What is the end-to-end cycle time from customer demand to delivered output, and is it declining or rising? What is the current rate-limiting constraint, and is there an active program to exploit and then elevate it? How quickly is a defect caught, and does the lowest-level worker have the authority to halt the line? What fraction of significant failures produces a shared, blameless post-mortem? Has the organization installed the equivalent of the UPR — a graded three-stage escalation from slow-new-intake, to upgrade-capacity, to controlled-termination — or does it skip directly from denial to catastrophic restructuring?
The Cautionary Case
Kodak is the cleanest example. The firm invented the digital camera in 1975 and held more than a thousand digital imaging patents. Its governance-level asset was unmatched. Its ribosomes could not translate. A film-era organizational architecture optimized for a chemical manufacturing process and a distribution network a century in the making could not make the proteins the new strategy required. GE under Jeff Immelt lost roughly $150 billion of market value because a Welch-era execution culture could not translate a “digital industrial” strategy. Sears under Eddie Lampert held strategic intent toward digital-physical integration while systematically starving the translation machinery; PP&E fell from $9 billion in 2007 to $2.6 billion in 2016. Strategy existed. The ribosomes had been starved.
Workers: The Enzymes
Workers are the catalytic layer. Cells do not have generic workers. They have enzymes — each with a specific substrate, a specific regulatory logic, and a specific operating window. Five features matter.
Specificity. Enzymes catalyze one reaction, or a narrow family. Trying to force a hexokinase to do the job of a protease is not a motivation problem; it is a category error. Tissue-specific isoforms exist because the same nominal chemistry is different in muscle than in liver. A product manager in a Series A startup is a different enzyme than a product manager on a mature platform team.
Saturation. Past V-max, additional substrate produces no additional product and accelerates denaturation. High performers are not infinite resources. They have a maximum velocity, and managers who do not learn it destroy their best enzymes.
Allosteric regulation. Enzymes are tuned by molecules binding far from the active site. This is what we vaguely call “culture.” The water-cooler story about what happened to the last person who raised a concern; the unspoken rule about how late is late — distal signals quantifiably shift worker activity at the active site.
Cofactors. Most enzymes are inert without specific partner molecules — NAD+, magnesium, vitamins. Skills and motivation are not enough. Tools, data access, and peer support are non-substitutable.
Denaturation. Enzymes outside their operating window — wrong pH, wrong temperature — lose their catalytic shape. The loss is not gradual incompetence; it is structural failure. Burnout, as Maslach’s research documents, has three dimensions: exhaustion, cynicism, reduced efficacy. It is the organizational equivalent of heat denaturation.
The Enterprise Translation
Self-Determination Theory (Deci and Ryan) has converged, across four decades and dozens of meta-analyses, on three conditions under which human workers catalyze at full rate: autonomy, competence, relatedness. Csikszentmihalyi’s flow is the catalytic optimum, achieved in a narrow skill-challenge band. Edmondson’s psychological safety is the pH and temperature of the workplace. Gallup’s 2024 data — global engagement at 21%, down from 23%, with cumulative low-engagement cost estimated at $8.9 trillion, roughly 9% of global GDP — measures what denaturation at civilizational scale looks like.
The Diagnostic
What is the measured score on the SDT triad of autonomy, competence, relatedness? What is the measured psychological safety score by Edmondson’s scale? What fraction of work time is spent in flow? What is the burnout score, segmented by team and tenure? Has any employee raised a substantive concern upward in the last 90 days and had it acted on? Is the firm investing in chaperones — onboarding, mentorship, peer support — at a rate approaching the 10% of protein budget that cells devote to them?
The Cautionary Case
Yahoo under Marissa Mayer’s 2013 remote-work ban is a textbook autonomy-thwarting case. Within 24 months the signature enzymes had denatured or left. The Sull, Sull, and Zweig analysis in MIT Sloan Management Review (2022) found that toxic culture was 10.4 times more predictive of attrition than compensation. The workers had not lost their skills. Their operating window had been destroyed.
Security: The Selective Boundary
The cell does not wall itself off. It selects. The plasma membrane is a carefully engineered filter that admits nutrients and signals while excluding threats. The immune system adds a second layer that finds and neutralizes whatever gets through. Two principles matter.
Selectivity, not impermeability. The membrane is porous by design. Specific channels, transporters, and receptors exist for each class of input. Endocytosis handles bulk intake. Tight junctions control lateral leakage. A cell that sealed itself entirely would die within hours.
Layered immunity. Innate immunity uses germline-encoded pattern receptors that recognize conserved pathogen signatures — fast, rule-based, non-learning. Adaptive immunity uses clonal selection: an enormous random repertoire of receptors is generated, those that recognize real threats are amplified, and a memory is preserved so that next encounter is faster. Thymic education enforces tolerance; cells that would attack self are deleted. When tolerance breaks, autoimmune disease follows. Type 1 diabetes, multiple sclerosis, and lupus are failures in which the immune system attacks its own tissues.
The Enterprise Translation
Security is not the IT department. It is the selective-admission function of the entire organization. COSO ERM and ISO 31000 provide the risk-governance skeleton. NIST and ISO 27001 operationalize the information-security membrane. The Three Lines of Defense — operational management, risk and compliance, internal audit — mirror the innate-adaptive-memory architecture of the immune system.
Nassim Taleb’s Antifragile supplies the decisive insight. The adaptive immune system is antifragile at the system level: exposure to pathogens strengthens future defenses. Organizations that systematically convert small shocks into institutional memory — through blameless post-mortems, red-team exercises, war-gamed scenarios — become antifragile. Organizations that suppress shock signals become fragile. The difference is structural, not cultural.
The Diagnostic
Is the risk map comprehensive across enterprise, financial, operational, cyber, reputational, geopolitical, supply-chain, and talent categories? Are the three lines genuinely independent, or does internal audit report to an executive it is supposed to audit? What is the mean time to detect, contain, and recover from security incidents, and is it declining? Does the firm have immune-privileged sites — skunkworks, internal ventures — where novel ideas are protected from the default organizational immune response? Has the firm experienced autoimmune-like symptoms: functions attacking each other, veto cultures, innovation units chronically resourced for failure?
The Cautionary Case
Equifax, 2017. An internal scan had identified the Apache Struts vulnerability months before the exploit. The patch was never applied. The intrusion persisted for 76 days. 147 million records lost. The membrane was designed correctly. A specific transport defect — a patching process the three-lines architecture failed to enforce — was not fixed. Target in 2013 came through an HVAC vendor. SolarWinds in 2020 was a supply-chain compromise at the trusted-software layer, effectively a viral infection of the firm’s own ribosomes. In each case the firm had security. What it lacked was the immune-system architecture that turns each infection into durable memory.
Environment: The Tissue Context
No cell survives alone. It lives embedded in an extracellular matrix — a mesh of structural proteins that is simultaneously scaffold and information medium — and in a tissue context that signals continuously. Change the matrix, and the cell changes. Detach the cell, and, in healthy tissue, it dies. This programmed death is called anoikis — literally, homelessness. Metastatic cancer cells survive by overriding it. Normal cells do not.
Three mechanisms matter.
Contact inhibition. Normal cells stop dividing when they reach confluence. Cancer cells lose this. Uncontrolled growth in a mature category is not a hallmark of health. It is a hallmark of cancer.
Paracrine signaling. Cells communicate through short-range chemical signals that decay over distance. The information-rich signal comes from nearby. Long-distance endocrine signaling carries less usable information. This is the strongest first-principles argument for why a quarterly analyst report is a poor substitute for a front-line conversation.
Anoikis. A cell detached from its proper matrix commits suicide. The tissue niche is not scenery; it is a source of survival signals. No signals, no survival.
The Enterprise Translation
Stakeholder theory (Freeman) is the direct analog of tissue-context signaling. The firm is embedded in a matrix of customers, suppliers, investors, regulators, and communities, each providing signals and constraints. Porter’s Five Forces specifies the mechanical constraints of the industry matrix. Institutional theory (DiMaggio and Powell) identifies the coercive, mimetic, and normative pressures pushing firms toward structural similarity — paracrine, endocrine, and juxtacrine signaling at scale.
Drucker’s dictum — “the purpose of a business is to create a customer” — is the anoikis-avoidance rule. A firm whose customers disappear, for whatever reason, dies. It does not matter how good its internal architecture is. Tissue incompatibility is fatal.
The Diagnostic
Who are the stakeholders, mapped by salience of power, legitimacy, and urgency, and is the map updated quarterly? If the firm’s core customer segment disappeared tomorrow, how long would cash last? Are customer-facing employees gathering and transmitting signal upward, or does the signal die at middle management? How many forward-looking regulatory changes in the next 36 months have been identified, and what is the response posture for each? In what environments would this firm rightly cease to exist, and is there an early-detection apparatus for those environments?
The Cautionary Case
Nokia is the most instructive case in recent memory because the firm had everything it needed to win. Market share. Technology. Engineering talent. It failed because the tissue niche — the mobile phone ecosystem — changed faster than Nokia’s internal differentiation could keep up. Vuori and Huy’s research in Administrative Science Quarterly (2016) documents the mechanism: middle managers who perceived the iPhone threat were silenced by top-management fear. Signal from the environment could not reach decision-makers. Kodak, Blockbuster, and BlackBerry fit the same template. The failure was not a cellular pathology. It was an inability to detect that the organism was no longer living in the right tissue.
Discussion
From Zygote to Organism: The Founder’s Arc
Developmental biology adds a stage-specific dimension to the framework. A zygote is totipotent: it can become any cell type. But it cannot yet do anything specific. Development proceeds through progressive commitment and differentiation, orchestrated by gene regulation, morphogen gradients, and epigenetic lock-in.
A startup begins as a zygote. The founder is simultaneously the DNA, the mitochondria and chemotaxis, the ribosomes, the enzymes, the membrane, and the environment interpreter. That is totipotency. It is also unsustainable beyond a narrow range. A founder who does not differentiate the functions is running a zygote that cannot develop past the first few cleavage divisions.
Noam Wasserman’s analysis of more than 10,000 founders shows that roughly four of five founder-CEOs are forced to step down — 60% within the first four years. Paradoxically, founders who give up more equity build more valuable companies. Success accelerates replacement. The issue is not talent. The issue is that differentiation must occur, and it cannot occur while a single cell holds all six functions.
A practical differentiation schedule, tested against Greiner’s growth phases and Adizes’s lifecycle:
At 1–9 employees, all six functions remain fused in the founder. At 10–30, workers differentiate first: the founder cannot personally catalyze every reaction. At 30–100, management differentiates: the founder cannot personally translate strategy for every team. At 100–300, leadership differentiates into a team rather than an individual, and external-environment sensing moves into specialized roles — sales, marketing, government affairs, investor relations. At 300–1,000, governance differentiates into a real board with real committees, and security becomes a named function. Above 1,000, all six must be fully differentiated. Continued founder-mode micromanagement is now pathological, regardless of the founder’s talents.
Paul Graham’s recent “founder mode” essay argues against reflexive professionalization. The argument has real merit. Founder mode preserves zygotic totipotency longer, at the cost of the differentiation that lets organisms become large. Manager mode differentiates earlier, at the cost of coherence. Neither is universally correct. The question is which is appropriate to the developmental stage. A zygote should not be run as a corporation. A corporation should not be run as a zygote.
Where the Analogy Breaks
The framework is powerful. It is not universal. Honest executives will want to know where it stops working.
Human agency. Cells have evolved responses; organizations have chosen strategies. A firm can be Lamarckian — deliberately acquiring learned traits — in ways a cell cannot. This accelerates adaptation. It also permits untested changes to propagate fast.
Rewritable rules. A board can rewrite the bylaws in a day. DNA cannot rewrite itself in response to reasoning. The governance analogy is strongest at the epigenetic layer, where cultural norms shape expression, and weakest at the level of formal code that humans can edit at will.
Non-conservative energy. Cells are strictly thermodynamically bound; every ATP must be earned. Firms can run on borrowed capital, debt, and goodwill for extended periods with no cellular equivalent. The mitochondrial analogy understates how often corporate energy is borrowed from the future.
Ethics. The literal cellular logics of apoptosis, anoikis, and immunological exclusion, applied to people, are inhumane. The framework is diagnostic and generative. It is not a license to treat human beings as enzymes.
The rule is clean. Use cellular biology wherever the mechanism is rigorous and the scale matches. Declare the limit wherever it does not. Handled with that discipline, the analogy is strength. Handled sloppily, it is a liability.
The Diagnostic Protocol
LE6 is designed to be run as a diagnostic, not read as a theory. Seven steps.
Step 1. Six-layer health assessment. Score each of the six layers red, yellow, or green on fidelity, function, and failure-mode indicators, using the diagnostic questions above.
Step 2. Developmental-stage assessment. Locate the firm on the zygote-to-mature axis. Identify which of the six functions remains fused with the founder or founding team. Ask whether that fusion is appropriate to the stage.
Step 3. Hallmarks audit. Score against the fourteen hallmarks of enterprise cancer. Any unit with five or more active hallmarks is at risk. Eight or more is pathological.
Step 4. Cascade analysis. Identify the highest-upstream layer in trouble. Trace the predicted cascade. Intervention at the root is high-leverage. Symptomatic intervention downstream is not.
Step 5. Environment-compatibility check. Apply the anoikis test. In what environments would this firm rightly cease to exist? What is the early-detection apparatus for those environments?
Step 6. Mortality-indicator scan. Review the specific failure indicators: no product-market fit at 24 months post-funding; runway shorter than the path to the next milestone; founding team still doing enzyme-level work past 100 employees; zero regrettable senior departures; declining NPS across three successive periods; chronic disengagement below industry median; absence of blameless post-mortems; a stages-of-decline signature from Collins’s How the Mighty Fall.
Step 7. Intervention design. Interventions are layer-specific and stage-specific. Governance interventions are slow and structural. Leadership interventions turn on specific hires and specific frames. Management interventions are process work. Worker interventions are environmental — change the pH, not the enzymes. Security interventions require layered architecture, not a bigger wall. Environmental interventions are strategic repositioning. The intervention must match the layer and the stage. Layer mismatch is the single most common reason expensive transformations fail.
Conclusion
The cell has been tested by 3.8 billion years of selection. Your company has been tested, if you are fortunate, for a few decades. Biology has figured out how to encode rules without freezing, generate energy without burning out, translate instructions without losing them, execute without denaturing, defend without walling off, and fit an environment without being captured by it. Every one of those is a problem your firm is currently solving — or failing to solve.
LE6 does not promise that any firm can live forever. Cells die too. What it offers is a diagnostic vocabulary precise enough to see the failure coming, and a framework structured enough to locate the intervention that still has time to work. The cautionary cases in this article — Boeing, Kodak, Nokia, Theranos, Enron, Wirecard, Yahoo, Equifax, Sears, GE, Lehman, FTX — are not tragedies of bad luck. They are tragedies of pattern-blindness. The patterns are there, in a system far older than any enterprise, waiting to be read. The first step is to read them.
• • •